Lefler Daniel S, Cuker Adam, Linkins Lori-Ann, Warkentin Theodore E, Pishko Allyson M
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
J Thromb Haemost. 2020 Aug;18(8):2018-2024. doi: 10.1111/jth.14897. Epub 2020 Jun 25.
Most patients with suspected heparin-induced thrombocytopenia (HIT) and an intermediate probability 4Ts score do not have HIT. We aimed to develop a metric based on the rate of platelet count fall to aid in discriminating HIT status among patients with an intermediate 4Ts score.
We derived a measure of the maximum 24-hour percentage decrease in platelet count (Fall ) in a cohort of patients with suspected HIT and an intermediate 4Ts score at the University of Pennsylvania. We validated this metric in a prospectively collected cohort of patients with suspected HIT and an intermediate 4Ts score from four hospitals in Hamilton, Ontario.
One hundred fifty-eight and 139 patients were included in the analysis from the derivation and validation cohorts, respectively. Fall was significantly higher in HIT-positive patients in the derivation cohort (49.6% versus 38.6%, P = .009) and validation cohort (43.5% versus 29.3%, P = .027). The area under the receiver operating characteristic curve was 0.68 (95% confidence interval [CI] 0.57-0.78) and 0.71 (0.59-0.83) in the two cohorts, respectively. At Fall ≥ 30%, sensitivity and specificity were 95.5% and 29.4% in the derivation cohort and 80.0% and 52.7% in the validation cohort.
Among patients with suspected HIT and an intermediate 4Ts score, Fall aided in discriminating HIT-negative from HIT-positive patients. Using a measure that accounts for the rate of platelet count fall may help to avoid unnecessary suspension of heparin and treatment with an alternative anticoagulant in HIT-negative patients with an intermediate probability 4Ts score, though further evaluation is warranted.
大多数疑似肝素诱导的血小板减少症(HIT)且4Ts评分中等的患者并非HIT。我们旨在制定一种基于血小板计数下降率的指标,以帮助区分4Ts评分中等的患者的HIT状态。
我们在宾夕法尼亚大学的一组疑似HIT且4Ts评分中等的患者中得出了血小板计数最大24小时百分比下降值(Fall)的测量方法。我们在安大略省汉密尔顿市四家医院前瞻性收集的一组疑似HIT且4Ts评分中等的患者中对该指标进行了验证。
分别有158例和139例患者纳入了推导队列和验证队列的分析。推导队列中HIT阳性患者的Fall显著更高(49.6%对38.6%,P = 0.009),验证队列中也是如此(43.5%对29.3%,P = 0.027)。两个队列中受试者工作特征曲线下面积分别为0.68(95%置信区间[CI] 0.57 - 0.78)和0.71(0.59 - 0.83)。当Fall≥30%时,推导队列中的敏感性和特异性分别为95.5%和29.4%,验证队列中为80.0%和52.7%。
在疑似HIT且4Ts评分中等的患者中,Fall有助于区分HIT阴性和HIT阳性患者。使用考虑血小板计数下降率的指标可能有助于避免在4Ts评分中等概率的HIT阴性患者中不必要地停用肝素和改用其他抗凝剂进行治疗,不过仍需进一步评估。